feed,title,long_url,short_url
ðŸ’°Barrons,Kymera Therapeutics Stock Soars 30%. Why Investors Are Excited About Its Anti-Inflammatory Drug.,https://barrons.com/articles/kymera-therapeutics-stock-anti-inflammatory-drug-b511b373?mod=RTA,
